Instead, BC is usually classified into three subtypes according to estrogen receptor (ER)/progesterone receptor (PgR) expression and HER2 overexpression [4] using immunohistochemistry (IHC) on three surrogate markers. This evidence concerns the gene ESR1 and breast cancer.